AtriCure prices $24M stock offering | Wall Street Beat

AtriCure (NSDQ:ATRC) priced a public offering of nearly 3.5 million shares of stock at $7.25 per share, saying it expects net proceeds of about $23.5 million.

The West Chester, Ohio-based medical device company said it granted underwriter Piper Jaffray a 30-day over-allotment option for another 521,000 shares.

"AtriCure plans to use the net proceeds from the offering for general corporate purposes and working capital," according to a press release.

Sign up to get our free newsletters delivered straight to your inbox

 GSI Group drops $83M on NDS Surgical Imaging
Bedford, Mass.-based GSI Group (NSDQ:GSIG) acquired San Jose, Calif.-based surgical and radiology display company NDS Surgical Imaging for $82.5 million in cash. 
Read more

 Nephros lands nearly $800k from Bellco royalty deal
Nephros (OTC:NEPH) said it landed a €600,000 ($797,000) royalty payment from Bellco.
Read more

 Pro-Dex investor starts proxy war
The AO Partners Group, which owns 21.6% of Pro-Dex (NSDQ:PDEX), is urging other investors to back its play to take over the Pro-Dex board.
Read more

 Immucor details $85M Lifecodes financing
Immucor (NSDQ:BLUD) said it’s financing the $85 million it agreed to pay Hologic (NSDQ:HOLX) for the Lifecodes business with an aggregate of $50 million in debt financing from Citigroup Global Markets Inc., JPMorgan Chase Bank and J.P. Morgan Securities. The remaining $35 million will be provided as equity from TPG Capital and "certain co-investors."
Read more

 Analysts’ ups and downs

• Abbott (NYSE:ABT): Jefferies & Co. reiterates "buy" rating, lowers price target from $87 to $39.
• AtriCure (NSDQ:ATRC): Leerink Swann sets "outperform" rating, ~$10 price target.
• Boston Scientific (NYSE:BSX): Stifel Nicolaus reiterates "buy" rating, increases price target from $6.50 to $7.
• Johnson & Johnson (NYSE:JNJ): Jefferies & Co. reiterates "hold" rating, raises price target from $75 to $79.
• Thoratec (NSDQ:THOR): Zack’s downgrades to "neutral" rating.

Building Better Companies at DeviceTalks Minnesota DeviceTalks Minnesota's leadership track is designed to provide attendees with insights on topics such as: Navigating the path to market Reimbursement Winning regulatory approval Corporate culture Entering global markets Leadership Join industry leaders and medical device professionals at the most awaited medtech conference of the year, DeviceTalks Minnesota. Use code SAVE15 to save 15%! REGISTER NOW